Composition :
Each film coated tablet contains :
Domperidone maleate 12.73 mg equivalent to
Domperidone 10 mg
Each 5 ml suspension contains :
Domperidone 5 mg
Indications :
ADULTS :
- For the treatment of nausea and vomiting from various origins in adults. Prophylactic use in post-surgery vomiting is not recommended.
- Treatment of nausea and vomiting induced by L-dopa and bromocriptine.
- For the symptomatic of Domperidone is discouraged.
CHILDREN :
Pediatric use is not recommended, except when indicated to prevent nausea and vomiting associated with cancer chemotherapy or radiotherapy.
Posology :
Dosage and frequency of administration depend on the severity and duration of symptoms.
For the treatment of nausea and vomiting
- Adults (including the elderly) : 10 – 20 mg with anyd interval of 4 – 8 hours.
- Children : 0,2 – 0,4 mg/kg with an interval of 4 – 8 hours
For symptomatic treatment of functional dyspepsia
- Adults (including the elderly) : 10 – 20 mg, 3 times daily, and once at bedtime
(10 – 20 mg) depending on clinical response, duration of treatment should not exceed 12 weeks.
- Children : not recommended.
Presentation :
Boxes of 10 strips, each containing 10 tablets
Reg. No. DKL9909314917A1
Bottles of 60 ml
Reg. No. DKL0109315833A1LIGHT |
